PCL, Inc.

₩6,040As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:241820Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (20.56%)
Div yield —
ROE (174.17%)
Medical Devices
Beta (5Y) 1.13
PE TTM —
TSR TTM —
Mkt cap ₩17.87B
ROIC (35.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩7,365
21.94%
(78.03%)
Hold 1|4|4|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
51.91
51.04
48.59
52.29
1.37%
(2.51%)
(6.44%)
(0.38%)
Revenue₩B
1.320
1.399
1.412
1.421
6.67%
11.60%
7.47%
7.56%
Peers (US$13.18M)
Cap (US$)
PE
21.47M
—
Capital
TTM
5Y
10Y
Leveragex
1.129
0.455
0.309
EBIT/Intx
4.614
1.040
1.246
Own earn%
(7.41)
(56.75)
(17.43)
Sh yield%
32.10
17.78
15.72
Owners
Insiders/Inst%
8.16
37.11
Short interest%
2.23
SBC / revenue%
3.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
0–10
$1 testx
—
Incr. ROIC%
1